Navigation Links
New tuberculosis test more than skin deep
Date:6/5/2014

A new screening process for tuberculosis (TB) infections in Canadian prisons could mean that more than 50 per cent of those screened won't undergo unnecessary treatment due to false positives.

According to research by Wendy Wobeser and medical resident Ilan Schwartz, a test for TB using interferon-gamma release assays (IGRA) will detect a pre-existing TB infection, or latent TB, that might not present itself for many years, or until the body becomes weakened by another source.

"It's fairly uncommon that latent TB will reactivate only about a 10 per cent chance," says Dr. Wobeser, the study's lead author and an infectious diseases expert at Queen's. "That said, given the crowding in corrections facilities, the mass exposure of inmates to TB could be disastrous."

The IGRA test was developed in the last 10-15 years and diagnoses a latent TB infection. The body's immune system is provoked with a small amount of protein from the TB virus and if the body has previously been infected then a reaction will occur and the patient's blood will test positive for TB.

The pre-existing tuberculosis skin test (TST) for TB has been used for over 100 years but comes with two main limitations.

  • The current test requires two visits to determine the results: one to perform the test and then another visit a couple of days later to read the results.
  • Depending on the patient's exposure to other mycobacteria or the BCG vaccine, the current TB test can give many false positives.

The study group included representation from Public Health Agency of Canada (PHAC), Public Health Ontario (PHO), Correctional Services Canada (CSC) and the local public health agency. Inmates were tested at a Canadian intake institution before moving on to different corrections facilities. Ninety-six inmates tested positive for TB via the TST test. Only 31 of these inmates were confirmed as true latent TB infection when using the IGRA test.

"What I found surprising was just how much discordance there was between the TST and IGRA tests," says Dr. Schwartz, who was a medical resident at Queen's when he started this research. "Historically, all of those who tested TB-positive by the TST test would have been subjected to 12 months of drug treatments that can have considerable side effects."

IGRA tests can't prove that latent TB infections will progress into active TB until the patient begins to show symptoms. Better tools to predict who will go on to develop active (and potentially infectious) TB are being actively pursued.

"It's such a slow disease progression that it's hard for us to say with certainty who will actually go on to develop TB," says Dr. Wobeser. "I hope that this test will eventually be used in corrections and is able to reduce people who might otherwise be treated unnecessarily for latent TB."


'/>"/>

Contact: Rosie Hales
rosie.hales@queensu.ca
613-533-6000 x77513
Queen's University
Source:Eurekalert

Related biology news :

1. Biosignatures distinguish between tuberculosis and sarcoidosis
2. Targeting tuberculosis hotspots could have widespread benefit
3. MIT-designed cooler preserves tuberculosis drugs, records doses
4. Research on improvements in diagnosing and treating tuberculosis
5. Millions of diabetics could die of tuberculosis
6. New approach of resistant tuberculosis
7. Iowa State, Ames Lab researchers study the structure of drug resistance in tuberculosis
8. High doses of Vitamin D help tuberculosis patients recover more quickly
9. Scientists reveal how natural antibiotic kills tuberculosis bacterium
10. Notre Dame research could provide new insights into tuberculosis and other diseases
11. Missing link discovered in the defence mechanism of the tuberculosis pathogen
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2016)... , Dec. 20, 2016  As part of its ... the leading personal genetics company, recently released its latest children,s ... . The book focuses on the topics of inheritance and ... Science Standards (NGSS) taught in elementary school classrooms in the ... a series by illustrator Ariana Killoran , whose previous ...
(Date:12/20/2016)... 2016   Valencell , the leading innovator ... STMicroelectronics (NYSE: STM), a global semiconductor leader serving ... today the launch of a new, highly accurate ... includes ST,s compact SensorTile turnkey multi-sensor ... sensor system. Together, SensorTile and Benchmark deliver the ...
(Date:12/16/2016)... DUBLIN , Dec 16, 2016 Research ... Access System Market - Global Forecast to 2021" report to ... ... projected to grow at a CAGR of 14.06% from 2016 to ... 2016, and is projected to reach 854.8 Million by 2021. The ...
Breaking Biology News(10 mins):
(Date:1/18/2017)... ... January 18, 2017 , ... Thirty-six startup companies in University City and Center ... of Community and Economic Development in 2016 as part of the Keystone Innovation Zone ... Keystone Innovation Zone and represent the highest number of awards to the largest number ...
(Date:1/18/2017)... PUNE, India , Jan. 18, 2017  Market Research Future ... Cancer Diagnostics Market is expected to grow at a CAGR of ... Highlights ... a disease caused due to the abnormal cell division without any ... and cause harm to them. These cancer cells can spread to ...
(Date:1/17/2017)... 17, 2017 Roka Bioscience, Inc. (NASDAQ: ROKA ... for the detection of foodborne pathogens today announced the appointment of ... Paul Thomas , the Company,s President and CEO since 2009, ... of Directors.  The changes are effective today. In addition, ... ...
(Date:1/17/2017)... -- Only nine percent of U.S. consumers believe pharmaceutical and ... percent believe health insurance companies do, according to a ... U.S. adults believe health care providers (such as doctors ... (23%). "We are in the midst of ... vice president of reputation management and public affairs at ...
Breaking Biology Technology: